JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Search

Cellectar Biosciences Inc

Închisă

2.97 7.22

Rezumat

Modificarea prețului

24h

Curent

Minim

2.9699999999999998

Maxim

3.06

Indicatori cheie

By Trading Economics

Angajați

11

Statistici piață

By TradingEconomics

Capitalizare de piață

15M

Deschiderea anterioară

-4.25

Închiderea anterioară

2.97

Cellectar Biosciences Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 feb. 2026, 23:57 UTC

Market Talk

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

8 feb. 2026, 23:47 UTC

Market Talk

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

8 feb. 2026, 23:43 UTC

Market Talk

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

8 feb. 2026, 23:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 feb. 2026, 23:34 UTC

Market Talk

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

8 feb. 2026, 23:26 UTC

Market Talk

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

8 feb. 2026, 22:55 UTC

Câștiguri

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

8 feb. 2026, 21:43 UTC

Market Talk

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

8 feb. 2026, 21:16 UTC

Market Talk

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

8 feb. 2026, 21:15 UTC

Market Talk

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

7 feb. 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 feb. 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 feb. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7 feb. 2026, 02:46 UTC

Achiziții, Fuziuni, Preluări

Big Money, High Anxiety -- Barrons.com

6 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 feb. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6 feb. 2026, 21:40 UTC

Achiziții, Fuziuni, Preluări

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6 feb. 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

6 feb. 2026, 21:17 UTC

Câștiguri

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 feb. 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 feb. 2026, 21:14 UTC

Achiziții, Fuziuni, Preluări

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6 feb. 2026, 21:13 UTC

Câștiguri

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6 feb. 2026, 21:13 UTC

Câștiguri

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6 feb. 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6 feb. 2026, 20:34 UTC

Câștiguri

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Comparație

Modificare preț

Cellectar Biosciences Inc Așteptări

Consens privind evaluarea

By TipRanks

Neutru

1 ratings

0

Cumpărare

1

Păstrare

0

Vânzare

Date financiare

$

help-icon Live chat